Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study

Jesse S Cohen1, Jeffrey Phillips2, Sandhitsu R Das2

  • 1Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Neurology, University of Florida, Jacksonville, FL, USA.

Neuroimage. Clinical
|December 15, 2024
PubMed
Abstract

Insights

Lewy body disorders (LBD) with Alzheimer's disease copathology (LBD/AD+) show greater medial temporal lobe atrophy than LBD alone. This atrophy correlates with memory deficits and tau pathology, particularly in specific regions like Brodmann Area 35.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Neurodegeneration

Background:

  • Lewy body disorders (LBD) feature alpha-synuclein pathology but often co-occur with Alzheimer's disease neuropathological changes (ADNC).
  • The medial temporal lobe (MTL) is crucial in AD, but the impact of AD copathology on MTL degeneration in LBD remains unclear.
  • Investigating MTL subregional atrophy in LBD with and without AD copathology (LBD/AD+) is essential.

Purpose of the Study:

  • To investigate the anatomical consequences of co-occurring LBD/AD+ pathology on MTL neurodegeneration.
  • To compare MTL subregional atrophy patterns between LBD/AD+ and LBD/AD- individuals using T1w MRI.
  • To explore the relationship between MTL atrophy, cognition, and neuropathology.

Main Methods:

  • Studied 167 individuals with LBD (PD, PDD, DLB) using T1w MRI and AD biomarkers or autopsy evidence of ADNC.
  • Classified individuals into LBD/AD+ and LBD/AD- groups based on ADNC evidence (neuropathologic criteria, amyloid PET, CSF β-amyloid).
  • Utilized the ASHS pipeline for MTL subregion volume/thickness measurements and linear regression to assess associations.

Main Results:

  • LBD/AD+ individuals exhibited decreased MTL subregion volume/thickness compared to LBD/AD-, notably in Brodmann Area 35 (BA35) and entorhinal cortex (ERC).
  • Significant correlations were found between verbal memory and MTL subregion volumes (hippocampus, BA35, ERC, PHC), and visuospatial memory with BA35 volume.
  • Autopsy data revealed lower ERC volume associated with higher ERC tau load.

Conclusions:

  • LBD/AD+ demonstrates greater T1w MRI-evidenced atrophy in multiple MTL subregions compared to LBD/AD-.
  • MTL subregional atrophy is linked to memory performance and tau pathology, largely aligning with AD Braak stages except for the posterior hippocampus.
  • Further longitudinal studies are required to confirm the hypothesized spread of neurodegeneration.

Related Concept Videos

Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
157
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476